West Pharmaceutical Services, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2025: USD 158.90 M

West Pharmaceutical Services, Inc. Depreciation And Amortization is USD 158.90 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 12.46% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • West Pharmaceutical Services, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 141.30 M, a 15.25% change year over year.
  • West Pharmaceutical Services, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 122.60 M, a -0.16% change year over year.
  • West Pharmaceutical Services, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 122.80 M, a 9.45% change year over year.
  • West Pharmaceutical Services, Inc. Depreciation And Amortization for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 112.20 M, a 7.99% change year over year.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased